Find articles by Millay, D
These effects may potentially provide a new therapeutic solution for stroke with specific beneficial effects on the CNS (i.e., reperfusion, amelioration of neuronal damage leading to recovery in the absence of memory, motor, and coordination deficits, and expression of specific genes in the hippocampus)
Starting therapy without evidence of hypogonadism was associated with an estimated 16.5% cumulative risk by 10 years of heart attack, ischemic stroke, cardiac arrest, or death, compared with 11.8% among men with documented hypogonadism
use within 14 days How-to-use guide Read the research protocol Concise reconstitution, dosing, and handling instructions
A systematic analysis for the global burden of disease study 2016